Literature DB >> 11299232

Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression.

T Kadokami1, C F McTiernan, T Kubota, C S Frye, G S Bounoutas, P D Robbins, S C Watkins, A M Feldman.   

Abstract

Tumor necrosis factor (TNF)-alpha plays a key role in the pathogenesis of septic shock syndrome, and myocardial TNF-alpha expression may contribute to this pathophysiology. We examined the myocardial expression of TNF-alpha-related cytokines and chemokines in mice exposed to lipopolysaccharide (LPS) and tested the effects of anti-TNF therapy on myocardial cytokine expression. Cytokine mRNA levels were measured by RNase protection assay, and protein levels in the plasma and myocardium were assessed by enzyme-linked immunosorbent assays. LPS (4 microg/g body wt ip) induced marked cytokine expression, including TNF-alpha, interleukin (IL)-1beta, IL-6, and monocyte chemotactic protein (MCP)-1, in both the plasma and myocardium. Pretreatment with adenovirus-mediated TNF receptor fusion protein (AdTNFR1; 10(9) plaque-forming units iv) decreased plasma cytokine levels. In contrast, whereas myocardial IL-1beta expression was also suppressed, expression of IL-6 and MCP-1 was not inhibited by AdTNFR1. In summary, anti-TNF treatment differentially altered the cytokine expression in the plasma and myocardium during endotoxemia. Inability to block myocardial expression of IL-6 and MCP-1 suggests a possible mechanism for the failure of anti-TNF therapies in the treatment of endotoxin shock.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299232     DOI: 10.1152/ajpheart.2001.280.5.H2281

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

1.  Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Roland Prondzinsky; Susanne Unverzagt; Henning Lemm; Nikolas-Arne Wegener; Axel Schlitt; Konstantin M Heinroth; Sebastian Dietz; Ute Buerke; Patrick Kellner; Harald Loppnow; Martin G Fiedler; Joachim Thiery; Karl Werdan; Michael Buerke
Journal:  Clin Res Cardiol       Date:  2012-01-03       Impact factor: 5.460

2.  Long non-coding RNA BANCR promotes interferon-β-induced cardiomyocyte apoptosis by targeting signal transducer and activator of transcription 1 in vitro.

Authors:  Shiqi Wang; Fuwei He; Zhenwei Li; Yewen Hu; Ning Huangfu; Daqi Xie
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

Review 3.  The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure.

Authors:  Alexandros Briasoulis; Emmanuel Androulakis; Theodoros Christophides; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

4.  Do cardiomyocytes mount an immune response to Group A Streptococcus?

Authors:  Zhi Li; Amy E Bryant; Stephanie M Hamilton; Clifford R Bayer; Yongsheng Ma; Dennis L Stevens
Journal:  Cytokine       Date:  2011-03-04       Impact factor: 3.861

5.  Cytokines as new treatment targets in chronic heart failure.

Authors:  Jan Kristian Damås; Lars Gullestad; Pål Aukrust
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

6.  Adiponectin ameliorates endotoxin-induced acute cardiac injury.

Authors:  Yoshio Watanabe; Rei Shibata; Noriyuki Ouchi; Takahiro Kambara; Koji Ohashi; Li Jie; Yoko Inoue; Toyoaki Murohara; Kimihiro Komori
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

7.  The combination of red palm oil and rooibos show anti-inflammatory effects in rats.

Authors:  Emma Katengua-Thamahane; Jeanine L Marnewick; Olawale R Ajuwon; Novel N Chegou; Gergő Szűcs; Péter Ferdinandy; Tamás Csont; Csaba Csonka; Jacques Van Rooyen
Journal:  J Inflamm (Lond)       Date:  2014-12-20       Impact factor: 4.981

Review 8.  Cytokine Storm-Definition, Causes, and Implications.

Authors:  Dominik Jarczak; Axel Nierhaus
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

Review 9.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

10.  Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease.

Authors:  Elizabeth A Droke; Brenda J Smith; Kelly A Hager; Megan R Lerner; Stan A Lightfoot; Barbara J Stoecker; Daniel J Brackett
Journal:  J Inflamm (Lond)       Date:  2007-09-07       Impact factor: 4.981

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.